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Cell adhesion to the extracellular matrix is required to exe-
cute growth factor (GF)-mediated cell behaviors, such as prolif-
eration. A major underlying mechanism is that cell adhesion
enhances GF-mediated intracellular signals, such as extracellu-
lar signal-regulated kinase (Erk). However, because GFs use dis-
tinct mechanisms to activate Ras-Erk signaling, it is unclear
whether adhesion-mediated enhancement of Erk signaling is
universal to all GFs. We examined this issue by quantifying the
dynamics of Erk signaling induced by epidermal growth factor,
basic fibroblast growth factor (bFGF), and platelet-derived
growth factor (PDGF) in NIH-3T3 fibroblasts. Adhesion to
fibronectin-coated surfaces enhances Erk signaling elicited by
epidermal growth factor but not by bFGF or PDGF. Unexpect-
edly, adhesion is not always a positive influence onGF-mediated
signaling. At critical subsaturating doses of PDGF or bFGF, cell
adhesion ablates Erk signaling; that is, adhesion desensitizes the
cell to GF stimulation, rendering the signaling pathway unre-
sponsive to GF. Interestingly, the timing of growth factor stim-
ulation proved critical to the desensitization process. Erk acti-
vation significantly improved only when pre-exposure to
adhesion was completely eliminated; thus, concurrent stimula-
tion by GF and adhesion was able to partially rescue adhesion-
mediateddesensitizationofPDGF- andbFGF-mediatedErk and
Akt signaling. These findings suggest that adhesion-mediated
desensitization occurs with rapid kinetics and targets a regula-
tory point upstream of Ras and proximal to GF receptor activa-
tion. Thus, adhesion-dependent Erk signaling is not universal to
all GFs but, rather, is GF-specific with quantitative features that
depend strongly on the dose and timing of GF exposure.
Cell adhesion plays a key role in regulating cellular behaviors
such as gene expression, cell survival, and proliferation.Normal
cells deprived of adhesion to the extracellular matrix undergo
cell cycle arrest (1, 2) and programmed cell death even when
soluble growth and survival cues are present (1, 3–5). This
adhesion dependence is often de-regulated during cancer
development, allowing transformed cells to acquire growth and
survival advantages over their normal counterparts (6–8).
Adhesion-independent survival and proliferation plays a role
not only in the build-up of cell mass during tumor formation
but also in the survival of cancer cells in foreign, secondary sites
during metastasis (6, 9, 10).
Because of the physiological importance of adhesion-medi-
ated cell regulation, significant attention has been given to
uncovering the underlying signaling mechanisms. One promi-
nent point of cross-talk between adhesion and growth factors
involves the serine/threonine kinase, extracellular signal-regu-
lated kinase (Erk).2 Several reports have shown that growth
factor-mediated Erk signaling is enhanced among cells adhered
to extracellular matrix (ECM) proteins (2, 11–20). In fact, this
adhesion-mediated enhancement of Erk signaling plays a cru-
cial role in cell cycle regulation. In NIH-3T3 fibroblasts, sus-
pended cells trigger only a transient Erk signal; however, when
adhered to FN, growth factor treatment supports both a sus-
tained Erk signal and subsequent progression through the cell
cycle (11).
Erk is a major signaling protein that is activated by a wide
array of stimuli, including several growth factors such as
PDGF, bFGF, and EGF (12–14). It is unclear whether adhe-
sion enhances Erk signaling in response to all of these growth
factors or whether only a subset of growth factors signal in an
adhesion-dependent manner. Growth factors use substan-
tially different mechanisms to trigger Erk signaling. Unlike
EGF, bFGF binding to the cell surface is mediated by two
distinct families of cell surface receptors (13). After ligand
binding, EGF receptors are phosphorylated on key tyrosine
residues that recruit signaling proteins. In contrast, bFGF
receptors phosphorylate the multidocking protein FSR2,
which subsequently serves as a scaffold to trigger down-
stream signaling pathways. In addition to activation path-
ways, growth factors differ in negative feedback mechanisms
that desensitize signaling (15, 16). For example, although
stimulation via EGF and PDGF results in serine/threonine
phosphorylation of their respective receptors, this receptor
phosphorylation results in Erk inhibition only in the cells
stimulated by PDGF. Interestingly, Erk activation in EGF-
stimulated cells remains unaffected (15). Such differences in
growth factor signaling mechanisms raise the hypothesis
that growth factors may differ in the extent to which their
stimulation of Erk signaling is adhesion-dependent.
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To begin to test this hypothesis, we measured the effect of
cell adhesion on Erk signaling by three growth factors (EGF,
bFGF, and PDGF). To measure the level of adhesion depend-
ence on both the magnitude and dynamics of the Erk signal, we
implemented a quantitative protocol for Western blot imaging
andanalysis.Thisquantitativeapproachrevealedthatadhesion-
dependent Erk signaling is selective to EGF in NIH-3T3 fibro-
blasts. Furthermore, our data reveal that adhesion is not always
a positive influence on GF-mediated Erk signaling. At a critical
subsaturating dose of PDGF and bFGF, cell adhesion actually
thwarts Erk signaling. Our results show that adhesion desensi-
tizes cells from subsequent GF-mediated activation of Erk; that
is, adhesion renders the signaling pathway unresponsive to GF
treatment. Interestingly, reducing the duration of cell adhesion
before GF stimulation proved critical in the desensitization
process. PDGF- and bFGF-mediated Erk signaling significantly
improved among adherent cells only when pre-exposure to
adhesion was completely eliminated; however, concurrent
stimulation by growth factors and adhesion was only able to
partially neutralize GF-mediated desensitization. Our findings
suggest that adhesion dependence of Erk signaling is not uni-
versal to all GFs but, rather, is GF-specific with quantitative
features that depend strongly on the dose and timing of adhe-
sion and GF exposure.
EXPERIMENTAL PROCEDURES
Cell Maintenance—NIH-3T3 fibroblasts (ATTC) were cul-
tured and maintained in 89% Dulbecco’s modified Eagle’s
medium (Invitrogen), 10% Donor Calf Serum  iron (Invitro-
gen), 1% PenStrep (Invitrogen). After2 days of growth, when
cells reached between 70 and 80% confluence, subconfluent
cells were suspended using 0.25% trypsin, EDTA (Invitrogen)
and reseeded onto tissue culture dishes.
Protein-coating Surfaces—Fibronectin (FN)-coated surfaces
were prepared by incubating 2ml of 5g/ml FN (Sigma) diluted
in Dulbecco’s phosphate-buffered saline (Sigma) in tissue cul-
ture dishes overnight at 4 °C. The dishes were gently rocked
during adsorption. The dishes were then blocked with 1mg/ml
heat-inactivated bovine serum albumin in phosphate-buff-
ered saline for 1 h at 37 °C. Poly-HEMA (PH)-coated surfaces
were prepared by incubating 5 ml of a solution containing 6
mg/ml PH (Sigma) dissolved in 70% biological grade ethanol
(Sigma) in uncovered tissue culture dishes overnight at room
temperature.
Cell Adhesion Experiments—NIH-3T3 cells were suspended
using 0.25% trypsin-EDTA, reseeded, and grown until 70–80%
confluent. Subconfluent dishes were starved in completely
serum-free media (99% Dulbecco’s modified Eagle’s medium
(Invitrogen), 1% PenStrep (Invitrogen), 1 mg/ml bovine serum
albumin (Sigma)) for 20 h to bring adhesion signals back to
basal levels. Serum-starved cells were suspended using 0.05%
trypsin. Trypsin activity was quenched by adding soybean tryp-
sin inhibitor (Sigma) to a final concentration of 0.5mg/ml. Cells
were re-suspended in serum-free media to a concentration of
5 105 cells/ml and were either plated onto FN-coated dishes
or PH-coated dishes; PH-coated dishes were rocked to prevent
cell aggregation.
After cells acclimated to the surface for varying lengths of
time (either 2.5, 1, or 0 h, as described in the figure legends),
cells were stimulatedwith the indicated amount of either PDGF
(Sigma), bFGF (Sigma), or EGF (Peprotech). Cells were lysed in
buffer containing 50 mM Tris (pH 7.5), 150 mM sodium chlo-
ride, 50 mM -glycerophosphate (pH 7.3), 10 mM sodium pyro-
phosphate, 30 mM sodium fluoride, 1% Triton X-100, 1 mM
benzamidine, 2 mM EGTA, 100 M sodium orthovanadate, 1
mM dithiothreitol, 10 g/ml aprotinin, 10 g/ml leupeptin, 1
g/ml pepstatin, and 1 mM phenylmethylsulfonyl fluoride.
Lysates were incubated in lysis buffer for 15 min on ice before
centrifugation and collection of the supernatant. Micro-BCA
protein assay kit (Pierce) was used to determine the total pro-
tein concentration.
Immunoblotting—Whole cell lysates were resolved by 10%
SDS-polyacrylamide gel electrophoresis and blotted onto a
polyvinylidene difluoride membrane. Blots were probed using
either an antibody against dually phosphorylated Erk (Cell Sig-
naling), Ser-473-phosphorylated Akt (Cell Signaling), Erk2
(Santa Cruz Biotechnology, Inc.), Sos (Santa Cruz), or caspase 3
(Upstate Biotechnology, Inc.). In the cases of Sos and caspase 3,
7 and 15% gels were used to better resolve high and lowmolec-
ular weight proteins, respectively. Blots were imaged and quan-
tified as described under “Results” and “Discussion.”
RESULTS
QuantitativeMeasurement of Erk Signaling—Toquantify the
extent to which different GFs induce adhesion-dependent Erk
signaling, we developed a systematic, quantitative Western
blotting protocol. Themethodology is based on digital imaging
using a cooled CCD camera that has a theoretically wider linear
dynamic range than standard film-based imaging (17, 18).
However, even when signals are within the detection limit of
the imaging system, data points do not always conform to the
expected linear trend (supplemental Fig. 1). We expect that
factors such as antigen saturation may contribute to the
observed non-linearity.
To address these sources of non-linearity thatmay be specific
to each blot, we developed a quantitativeWestern blotting pro-
tocol that employs standard samples to establish the linear
dynamic range of each blot. The standards are a set of dilutions
of a positive control lysate as illustrated for an anti-ErkWestern
blot in Fig. 1A. The band intensities from the standard lanes are
quantified, and the working linear range is established empiri-
cally for each blot (Fig. 1B). Band intensities from the lanes
loaded with lysates of interest are then confirmed to fall within
the linear dynamic range (Fig. 1B); any band intensities that fall
outside the linear dynamic range are discarded. The sole excep-
tions to this requirement are samples whose basal signal cannot
be distinguished from background noise; a typical example is
the initial time point after serum starvation. This approach
ensures that the measurements of Erk expression levels lie
within the linear dynamic range of eachWestern blot. A similar
approach is applied to quantify phospho-Erk and phospho-Akt.
To adjust for unequal loading, the band intensity associated
with a phosphoprotein (e.g. phospho-Erk) is normalized to the
band intensity of an equal-loading control, such as total Erk
(ErkT).
Differential Adhesion Dependence of Growth Factor Signaling
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We note that the same standards are not used in every blot.
Rather, dilutions of a positive control lysates are used as stand-
ards. This approach ensures that for a particular blot, the band
intensities of the standards will encompass nearly the entire
linear range of the blot. Such an approach increases the likeli-
hood that the band intensities of the lysates of interest will fall
within the linear range. To ensure that data collected from two
distinct blots can be compared with one another, we included a
common reference point in each blot. This reference is a sample
generated under the same stimulation conditions. The data are
then always analyzed and reported relative to this reference
point.
EGF, but Not PDGF and bFGF, Induces Adhesion-depend-
ent Erk Activation—Using this quantitativeWestern blotting
protocol, we measured the Erk signaling response to growth
factor treatment of cells adhered on FN or held in suspension.
Our initial experiments used growth factor concentrations well
above the dissociation constant (Kd) (Table 1). At these saturat-
ing growth factor concentrations, EGF-mediated Erk signaling
is enhanced by cell adhesion. Cells adhered on FN exhibit
3-fold greater Erk activation than cells held in suspension in
response to treatment with EGF for 12 min (Fig. 2A). Mean-
while, neither bFGF- nor PDGF-mediated Erk signaling at a
single early time point are adhesion-dependent (Fig. 2A). These
results suggest that some GFs (EGF) signal better via the Erk
pathway when in an adhesive setting, whereas other factors
(PDGF, bFGF) promote Erk signaling in an adhesion-indepen-
dent manner.
These observations are based on a single, early time point.
However, others have shown that GF-mediated Erk signaling
may exhibit different dynamical features in adhered versusnon-
adhered cells (11, 19–21). For example, in both adhered and
suspended cells, PDGF stimulates Erk equivalently at early
times, but only the adhered cellsmaintain a sustained Erk signal
(21). To examine whether adhesion affects the dynamics of GF-
mediated Erk signaling, we measured a full time-course of Erk
signaling in response to each of the three GFs. For EGF-stimu-
lated cells, the early phase of Erk activation (1 h) is adhesion-
dependent, whereas the late phase of the signal reaches a nearly
equivalent, basal signal for both adhered and suspended cells
(Fig. 2B). Furthermore, both the adherent and suspended cells
reachmaximum signal intensity after only 6min of stimulation.
Thus, the kinetics of EGF-induced Erk signaling is similar in
both adherent and suspended cells, although signal magnitude
is clearly adhesion-dependent.
In contrast, Erk activation in cells stimulated with either
PDGF (Fig. 2C) or bFGF (supplemental Fig. 2) was adhesion-
independent. For both growth factors, the Erk signal reached a
similar maximum after 30 min of stimulation. Furthermore,
in the case of PDGF, the Erk signal decays with similar kinetics
for both suspended and adhered cells. In the case of bFGF,
however, the Erk signal is sustained at near-maximum levels in
both adhered and suspended cells. Thus, measurements of the
complete dynamics of Erk signaling show that EGF, but not
PDGF or bFGF, induces Erk signaling in an adhesion-depend-
ent manner.
Subsaturating Doses of PDGF or bFGF Reveal Negative Adhe-
sion-GF Synergism—The apparent lack of adhesion depend-
ence in Erk signaling for bFGF and PDGF may be linked to the
fact that high concentrations of the growth factors were used.
In this concentration regime, excessive GF signaling may over-
come the need for cell adhesion. Thus, we hypothesized that for
PDGF and bFGF, Erk signaling may be adhesion-dependent if
concentrations are near or less than Kd (Table 1) were used. To
test this possibility, we measured GF-mediated Erk signaling
across a broad range of GF concentrations.
FIGURE 1.QuantitativeWestern blot imaging and analysis. A, a represent-
ative anti-Erk2 Western blot of NIH-3T3 cell lysate. Lanes 1–4 contain lysates
from cells that have been held in suspension for 2.5 h followedby stimulation
with 1 of 3 different growth factors for 12 min. Lanes 5–8 represent cells that
were adhered on FN-coated dishes for 2.5 h before stimulation for 12 min by
1 of 3 growth factors. Different relative amounts of the standard lysate were
loaded in lanes 9–13. In this test case the standard lysate was derived from
cells adhered on FN-coated dishes for 2.5 h before stimulationwith amixture
of 4 growth factors (800 pM EGF, 800 pMPDGF, 1000 pMbFGF, 1M insulin) for
40min. SF, serum-freemedium. B, quantification of Erk2 band intensities and
the identification of the linear dynamic range. The Erk2 band intensities were
quantified for the blot depicted in panel A. The intensities of the standard
bands (asterisks) areplottedas a functionof the relative amountsof the stand-
ard sample (bottom x axis). The upper and lower bounds (dashed lines) of the
empirically verified linear dynamic range are indicated. The intensities of the
total Erk bands for the cells adhered to fibronectin (solid squares) and cells
held in suspension (open circles) are plotted as a function of the treatment
condition (top x axis).
TABLE 1
Summary of growth factor properties including the critical
concentration at which adhesion-mediated desensitization occurs
NA, not applicable.
Growth
factor Mr Kd
Critical concentration,
GFc
pM pM
EGF 6.20 670 (Ref. 43) NA
PDGF 24.6 100–1000 (Refs. 44–50) 8.1
bFGF 16.4 30 (Refs. 37 and 51)a 1.2
aAt low concentrations, bFGF will bind almost exclusively to high affinity sites
(51); thus, the reported Kd corresponds to bFGF interaction with its high
affinity receptor.
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In the case of EGF, varying its concentration over 3 orders of
magnitude did not affect the observed adhesion-mediated
enhancement in Erk signaling (Fig. 3A). Regardless of its con-
centration, EGF stimulated an 3-fold greater Erk response
among adherent cells than among suspended cells (Fig. 3A). In
contrast, experiments with different PDGF and bFGF concen-
trations revealed an unexpected response (Fig. 3, B andC). At a
critical growth factor concentration (8 pMPDGFor 1 pMbFGF),
cells in suspension induced Erk signaling to a significantly
greater extent than adherent cells. Above the critical PDGF and
bFGF concentration, adhered and suspended cells responded
equivalently (Fig. 3, B and C). At the critical PDGF and bFGF
concentration, the suspended cells responded 7- and 13-fold
better, respectively, than their adherent counterparts (Fig. 3, B
and C). These results reveal a negative synergism between
adhesion and GF stimulation; adhesion thwarts Erk activation
at critically low doses of PDGF and bFGF.
Because this negative synergy was observed at a specific time
point in Erk signaling, we investigated the dynamics of Erk sig-
naling more completely at the critical PDGF concentrations
(Fig. 4) and bFGF concentrations (supplemental Fig. 3). At the
critical PDGF concentration, adherent cells were unable to
induce Erk signaling during the entire time course (Fig. 4). In
contrast, Erk signaling in suspended cells was substantial
throughout the entire time course (Fig. 4). Thus, the observed
negative synergismbetween adhesion andGF stimulation is not
an artifact of selecting a specific time point; rather, the entire
dynamics of PDGF-mediated Erk signaling is suppressed
among adherent cells at the critical PDGF concentration. Sim-
ilar results were observed for bFGF as adhesion completely
ablated bFGF-mediated Erk activation (supplemental Fig. 3).
Adhesion Desensitizes PDGF- and bFGF-mediated Erk
Signaling—The observed negative synergy reveals that cell
adhesion to FN selectively abrogates PDGF- and bFGF-medi-
ated Erk signaling when these growth factors are present at low
concentrations. These observations raise the possibility that
adhesion desensitizes subsequent Erk activation. Desensitiza-
tion refers to a state in which a signaling pathway becomes
unresponsive to stimuli. This desensitized or refractory state
may occur when a signal triggers negative feedback mecha-
nisms that persist and prevent re-activation of the signal in
response to new stimuli. Published reports have shown that
growth factor stimulation inhibits Erk signaling in response to a
second challenge of growth factor (22–24). Our results suggest
that adhesion to FN may also desensitize Erk signaling to a
select subset of growth factors (PDGF and bFGF).
FIGURE2.AdhesiondependenceofErksignalingat saturatingconcentra-
tions of growth factors. Serum-starved cells were either held in suspension
via PH-coated dishes or allowed to adhere on FN-coated dishes for 2.5 h
before stimulation with serum-free medium containing a single growth fac-
tor at the indicated concentrations. After the desired time of exposure to
growth factor, cells were lysed, and lysates were analyzed via Western blot
with the anti-phospho-Erk and anti-Erk antibodies. The relative amount of
active Erk (ppErk) normalized to the equal-loading control, total Erk (ErkT), is
reported for the different treatment conditions. A, adhesion enhances Erk
signaling in response to EGF, but not bFGF or PDGF, stimulation. Cells held in
suspension (empty) and those adhered to FN (filled) were stimulatedwith the
indicated GF-containing medium or with serum-free medium (SF) and were
lysed after 12 min of stimulation. Error bars represent sample S.E. (n 2–9).
The single asterisk denotes that Erk activation in the suspended and adherent
cells is statistically similar. The double asterisk denotes that ERK activation in
the suspended and adherent cells is statistically different (p  0.01) using
Student’s t test. B, adhesion enhances EGF-mediated Erk signaling over the
entire time course. Cells held in suspension (empty circles) or allowed to
adhere on FN (solid square) were stimulatedwith 800pMEGF for the indicated
times. Error bars represent sample S.E. (n 2–4). The double asterisk denotes
that ERK activation in the suspended and adherent cells is statistically differ-
ent with p 0.05 (6 min) and p 0.09 (12 min). All p values were computed
usingStudent’s t test.C, PDGFactivates Erk in anadhesion-independentman-
ner over the entire time course. Cells held in suspension (empty circles) or
allowed to adhere on FN (solid squares) were stimulatedwith 800pMPDGF for
the indicated times. Error bars represent sample S.E. (n  2–4). The single
asterisk denotes that ERK activation in the suspended and adherent cells is
not statistically different using Student’s t test.
Differential Adhesion Dependence of Growth Factor Signaling
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Consistentwith this hypothesis of adhesion-mediated desen-
sitization, cell adhesion to FN in the absence of growth factors
promotes Erk activation (Fig. 5). Adhesion rapidly stimulates
the Erk pathwaywithmaximal activation occurring by12min
after cell seeding. This adhesion-mediated Erk signaling may
trigger negative feedback loops that desensitize cells to subse-
quent Erk signaling by PDGF and bFGF. If desensitization is
responsible for reduced PDGF- and bFGF-mediated Erk signal-
ing, then reducing the duration of cell adhesion before growth
factor stimulation might alleviate this suppression. Because
cells were seeded 2.5 h before stimulation in all previous exper-
iments, we tested this hypothesis by measuring PDGF-medi-
ated Erk signaling among cells that were exposed to FN-coated
surfaces for shorter times, specifically 1 and 0 h (Fig. 6,A and B,
respectively). In the 0-h case, cells were concurrently stimu-
lated with growth factor and plated onto FN-coated dishes.
Reducing the duration of adhesion significantly enhanced
PDGF-mediated Erk signaling among adherent cells. Although
Erk signaling was severely attenuated among cells that had
adhered for 2.5 h (Fig. 4), reducing adhesion time to 1 h only
slightly improved Erk signaling (Fig. 6A). However, eliminating
pre-exposure to adhesion altogether by concurrent stimulation
with PDGF significantly improved Erk signaling among adher-
ent cells (Fig. 6B). To quantify the enhancement in PDGF-me-
diated Erk signaling in response to decreasing the duration of
adhesion, we integrated the time course of Erk signaling for
cells held in suspension or adhered on FN for 0, 1, and 2.5 h (Fig.
6C). When the pre-exposure time to adhesion was reduced
from 2.5 to 0 h, the integrated Erk signal increased 5-fold.
Notably, even concurrent stimulation was unable to rescue
PDGF-mediated Erk activation to the same level as that
observed in suspended cells, suggesting that adhesion-medi-
ated desensitization occurs rapidly. The rapid timescale of
adhesion-mediated desensitization is consistent with the fact
that cell adhesion to FN significantly activates Erk within 12
min of cell seeding (Fig. 5).
Mechanisms Underlying Adhesion-mediated Desensitization—
The hyperphosphorylation of Sos is a prominentmechanism in
FIGURE 3. Adhesion dependence of Erk signaling across a wide range of
growth factor doses. NIH-3T3 cells were treated as described in the legend to
Fig. 2A, except that cells were stimulated with serum-free medium containing
different doses of EGF for 12min (A), PDGF for 30min (B), or bFGF for 30min (C).
The response of cells held in suspension (empty) is comparedwith cells adhered
on FN (filled). A, error bars represent sample S.E. (n  2–4). The double asterisk
denotes that ERKactivation in suspendedandadherent cells is statistically differ-
entwith p 0.001 (800pm) andp 0.07 (80 pm). B, error bars represent sample
S.E. (n 2–4). The double asterisk denotes that ERK activation in suspended and
adherentcells is statisticallydifferentwithp0.04.C,errorbars represent sample
S.E. (n 2–4). The double asterisk denotes that ERK activation in the suspended
cells is statically different with p 0.07. All p values were computed using Stu-
dent’s t test. ppErk, active Erk; SF, serum-freemedium.
FIGURE4.Timecourseofadhesion-dependentErk signalingat thecritical
PDGF concentration. Serum-starved NIH-3T3 cells were held in suspension
(empty circles) or adhered on FN (solid squares) as described in the legend to
Fig. 2. Cells were stimulated with serum-free medium containing 8 pM PDGF
and lysed at the indicated times. The relative amount of active Erk normalized
to total Erk is reported. Error bars represent sample S.E. (n 2–4).
Differential Adhesion Dependence of Growth Factor Signaling
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GF-mediated desensitization of Erk (25–29). To determine
whether cell adhesion to FN desensitizes the Erk pathway in a
similar manner, we measured the effect of cell adhesion on the
hyperphosphorylation of Sos using a gel retardation assay (Fig.
7). The mobility of Sos did not change among cells that were
plated on FN-coated substrates in the absence of GF (Fig. 7,
0–240 min lanes). In contrast, a positive-control treatment
with PDGF induces a clear and significant retardation in Sos
mobility (Fig. 7, PC lane). Thus, adhesion-mediated desensiti-
zation of Erk signaling does not involve hyperphosphorylation
of Sos.
To determine whether adhesion-mediated suppression of
PDGF and bFGF signaling was specific to the Erk pathway, we
measured Akt signaling under similar conditions. PDGF- and
bFGF-mediated Akt phosphorylation was also significantly
diminished among adherent cells (Fig. 8 and supplemental Fig.
4, respectively). In addition, PDGF-mediated Akt activation
among adherent cells significantly improved as adhesion time
on FN was decreased (Fig. 8). Although reducing the duration
of adhesion from 2.5 to 1 h only slightly improved Akt signaling
(compare Figs. 8,A andB), concurrent stimulation significantly
improved Akt signaling among adherent cells (Fig. 8C). Indeed,
the integrated Akt signal shows a trend identical to that of the
integrated Erk signal. Although the integrated Akt signal for
suspended cells remains constant for adherent cells, the signal
clearly increases as the duration of adhesion on FN is reduced
(Fig. 8D). Because adhesion suppresses both Erk and Akt sig-
naling, it suggests that adhesion-mediated desensitization of
PDGF and bFGF signalingmay occur at or above the level of Ras
activation but independent of Sos regulation.
DISCUSSION
This study demonstrates that cell adhesion has quantitatively
intricate effects on GF-mediated Erk signaling. We report that
the effect of cell adhesion is specific to the type of growth factor,
its dose, and the timing of stimulation. Our system exclusively
uses NIH-3T3 fibroblasts that are stimulated in defined
medium.We find that adhesion to FN selectively enhances Erk
signaling elicited by EGF but has no effect on bFGF- or PDGF-
mediated Erk activation. Unexpectedly at concentrations of
PDGF and bFGF (GFc) that are significantly less than Kd (Table
1), cell adhesion severely attenuatesGF-mediated Erk signaling.
Thus, adhesion not only enhances cell response to specific
growth factors but also filters out potentially noisy signals from
low levels of growth factor. This aspect of adhesion-GF cross-
talk may play an important role in buffering cell response to
noisy background levels of GF stimulation. These results reveal
that the cross-talk between adhesion and growth factor signal-
ing has intricate quantitative features, consistent with the
extensive connectivity between adhesion and growth factor sig-
naling pathways (14, 30, 31).
Our observation that adhesion to FN enhances EGF-medi-
ated Erk signaling is consistent with other reports (32). Our
results further demonstrate that adhesion does not enhance
FIGURE 5. Adhesion-mediated Erk activation. Serum-starved NIH-3T3 cells
were suspended and re-plated on FN-coated plates as described in the leg-
end of Fig. 2. Cells were lysed at the indicated times after plating without
growth factor stimulation. Lysates were analyzed by SDS-PAGE and Western
blotting with an anti-phospho-Erk antibody (top panel) and an anti-Erk anti-
body (bottom panel) as an equal loading control.
FIGURE 6. Thedependence of PDGF-mediated ERK signaling on thedura-
tion of pre-exposure to FN-coated surfaces. Serum-starved NIH-3T3 cells
were held in suspension (empty circles) or adhered on FN-coated plates (solid
squares) as described in the legend to Fig. 2. The duration cells spent in sus-
pension or adhered to FN before stimulation with 8 pM PDGF was reduced
from 2.5 h to 1 h (A) or 0 h (B). The integral of the ERK time-course for all three
acclimation times are shown in C. For A and B, error bars represent sample S.E.
(n 3–6). For C, the error bars represent propagated error when the trape-
zoid rule is used to calculate the integrated signal.
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either PDGF- or bFGF-mediated Erk signaling in NIH-3T3
cells, a finding that is contrary to some reports (11, 19–21). In
one such report bFGF treatment was found to induce sustained
Erk signaling that supports cell cycle progression of NIH-3T3
fibroblasts seeded on FN-coated surfaces (33). However, the
3T3 cells used express exogenous human 51 integrin,
whereas our cell system expresses only endogenous integrin
adhesion receptors. Furthermore, both the aforementioned
study and others using NIH-3T3 cells supplement the growth
factor-containing medium with serum (11, 19). This serum
supplement is essential to maintain long-term cell viability, a
clear requirement for studying cell cycle progression.Our stud-
ies, in contrast, employ serum-freemedium supplementedwith
specific growth factors. We have carefully assayed cell death
under serum-free conditions by trypan blue staining and by
Western blotting for caspase 3 cleavage (data not shown). Our
measurements show that cells held in suspension or adhered on
FN-coated plates remain viable for 4–5 h in serum-free condi-
tions. Thus, all reported results are gathered in this time win-
dow and offer a clear indication of how Erk signaling by each
growth factor is influenced by adhesion without confounding
contributions from serum.
In addition to serum, cell type differences may also contrib-
ute to apparent differences in adhesion dependence of Erk sig-
naling. Kazlauskas and co-workers (21) showed that PDGF
treatment of mouse embryo fibroblasts adhered on FN induces
sustained Erk activation, whereas cells seeded on poly-lysine
support only a transient Erk signal. The difference between our
results and those of Kazlauskas and co-workers (21)may be due
to the use of mouse embryo fibroblast versus NIH-3T3 cells.
Moreover, themouse embryo fibroblast strain used in the study
lacks PDGF receptor and expresses endogenous PDGF recep-
FIGURE 7. The effect of cell adhesion on Sos hyperphosphorylation.
Serum-starved NIH-3T3 cells were suspended and re-plated on FN-coated
plates as described in the legend of Fig. 2. Cells were lysed at the indicated
times after plating without growth factor stimulation. Lysates were analyzed
by SDS-PAGE andWestern blotting with an anti-Sos antibody. A shift in total
Sos indicates presence of the hyperphosphorylated form of Sos. The lane
marked PC represents the positive control for the hyperphosphorylated form
of Sos and contains cells that have been adhered to fibronectin for 2.5 h
before stimulation by 800 pM PDGF for 12 min.
FIGURE 8. Adhesion dependence of PDGF-mediated Akt signaling. Serum-starved NIH-3T3 cells were held in suspension (empty circles) or adhered on FN
(solid squares) for 2.5hasdescribed in the legend toFig. 2. Cellswere then treatedwithPDGFand lysedat the indicated timepoints. The level of phosphorylated
Akt (pAkt) was quantified andnormalized to the amount of total cellular Erk (ErkT). The duration forwhich cellswere either held in suspension or adhered on FN
was reduced from 2.5 h (A) to 1 h (B) or 0 h(C). The integrated area for all three acclimation times is shown inD. For A and B, error bars represent the sample S.E.
(n 3–6). For D, the error bars represent propagated S.E. when the trapezoid rule is used to approximate the integrated signal.
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tor; our NIH-3T3 cells express both isoforms. Thus, the com-
plement of homo- and heterodimer receptors available for
binding PDGF-BB and for intracellular signaling are likely to be
different in these two cell types.
Because of both the differences in cell types and receptor
expression profiles as well as the potentially confounding con-
tributions from serum, it remains unclear whether adhesion-
dependent Erk signaling is specific to particular growth factors.
We sought to address this issue by developing a system that
utilizes only NIH-3T3 fibroblast cells expressing endogenous
integrins. Furthermore, growth factor stimulation was limited
to use of only one growth factor in defined media; thus, no
serum was used during the course of the experiments. There-
fore, our data begin to provide a systematic comparison of the
cross-talk between adhesion and three different growth factors.
We show that adhesion to FNenhances Erk signaling elicited by
EGF but not by bFGF and PDGF. Our observation that adhe-
sion-mediated enhancement of Erk signaling is not a universal
property of all growth factors is consistent with our previous
findings in Chinese hamster ovary cells. In these cells the
dynamics and magnitude of insulin-mediated Erk signaling is
unaffected by cell adhesion to FN (34). Rather, adhesion and
insulin synergistically affected IRS-1 phosphorylation en route
to co-regulating cell cycle activity.
The specificity of adhesion dependence might be explained
by intrinsic differences in how the receptors of these growth
factors signal to Erk. Although all three growth factors employ
the canonical Ras-mitogen-activated protein kinase cascade to
activate Erk, there are significant differences in the upstream
machinery that connect to the core Ras/mitogen-activated pro-
tein kinase signaling module. Although EGF receptors recruit
the necessary signaling proteins mostly by themselves (13),
bFGF receptors rely on the formation of a multidocking signal-
ing protein complex to recruit themajority of signaling compo-
nents (35). In addition, bFGF binds to two distinct families of
cell surface receptors, the first being the bFGF receptor-tyro-
sine kinase and the second being heparin sulfate proteoglycans
(36, 37). The binding to and signaling from two distinct recep-
tor families provide additional layers of control and complexity
to bFGF-mediated signaling to Erk (38).
In addition to utilizing different mechanisms for activating
the Ras/mitogen-activated protein kinase module, growth fac-
tor receptors differ in their susceptibility to negative regulatory
mechanisms. For example, serine/threonine phosphorylation
of EGF and PDGF receptors has been shown to affect the two
receptors differently. G protein-coupled receptor kinase 2-me-
diated serine/threonine phosphorylation of the PDGF receptor
results in a decrease in PDGF receptor tyrosine phosphoryla-
tion, which correlates to an observed decrease in Erk activation
by PDGF stimulation (15). In contrast, G protein-coupled
receptor kinase 2-mediated serine/threonine phosphorylation
has no effect on the tyrosine phosphorylation of the EGF recep-
tor, and subsequent Erk activation is also not affected. In sum-
mary, there are distinct pathways by which growth factors acti-
vate the Ras/mitogen-activated protein kinase module as well
as differences in growth factor receptor sensitivity to negative
regulatorymechanisms. Cell adhesionmay also couple to path-
ways unique to EGF, thereby selectively enhancing EGF-medi-
ated Erk signaling.
Although adhesion selectively enhances EGF-mediated Erk
signaling at saturating growth factor concentrations, an
intriguing feature of adhesion dependence was found at low,
subsaturating doses of growth factors. PDGF- and bFGF-medi-
ated Erk signaling is substantially attenuated among cells
adhered on FN. This adhesion-mediated suppression of growth
factor-induced Erk signaling is alleviated if the duration of cell
adhesion is reduced. These observations suggest that cell adhe-
sion rapidly triggers mechanisms that desensitize Erk signaling
by low concentrations of PDGF and bFGF.
Desensitization of the ERK signaling pathway has been
reported in response to growth factor stimulation. Growth hor-
mone (GH) induces Erk activation in HA cells; however, re-ex-
posure toGH in cells that have been pretreatedwith thisGH for
3 h fails to stimulate ERK (23). Similar desensitization of Erk
activation has been shown in insulin-treated Chinese hamster
ovary cells expressing insulin receptors (CHO/IR). Although
Erk activation occurs upon initial insulin exposure, a second
exposure to insulin fails to induce Erk signaling (24). Compara-
ble insulin-mediated desensitization to three independent
G-coupled ligands has been observed in 3T3-LI adipocyte
cells (22).However, in these cells, insulin pretreatment does not
desensitize EGF-mediated ERK activation. In contrast to insu-
lin and EGF, heterologous desensitization has been observed
between EGF and PDGF (39). Swiss-3T3 cells first exposed to
PDGF fail to induce Erk activation upon a subsequent treat-
ment with either PDGF or EGF. The converse is also observed;
initial exposure to EGF inhibits subsequent stimulation of ERK
signaling by PDGF or EGF treatment. Hence, there is precedent
for desensitization to selectively affect a subset of growth
factors.
A prominent mechanism by which GF desensitizes ERK sig-
naling in response to subsequent GF stimulation involves Sos
hyperphosphorylation (25–28). However, our results demon-
strate that adhesion to FN does not induce Sos hyperphospho-
rylation, suggesting that adhesion-mediated desensitization
does not occur at the level of Sos regulation.
Our results suggest that the time scale of desensitization is
remarkably rapid. Thus, although Sos is not the target of desen-
sitization, another signal extremely proximal to growth factor
detectionmust be involved. Consistentwith this possibility, our
results show that both Akt and Erk signaling are subject to
adhesion-mediated desensitization, suggesting that Ras or
some other common upstream element is the point of desensi-
tization. In fact, several growth factor receptors directly inter-
act with adhesion receptors (40). Although the association of
growth factor receptors with adhesion receptors has been pre-
dominantly correlated with positive synergism, it may also
sequester and inhibit the activity of low levels of ligand-bound
growth factor receptors. Indeed, such heterologous desensiti-
zation by receptor sequestration has been demonstrated for
EGFR and PDGF receptor (39). Another possiblemechanismof
growth factor desensitization may involve direct interactions
between growth factors and ECM proteins. Sequestration of
transforming growth factor , vascular endothelial growth fac-
tor, and hepatocyte growth factor by ECM is well documented
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(41). In fact, vascular endothelial growth factor has recently
been shown to bind specific sites on FN, suggesting potential
sequestration in more basic reconstituted systems. Thus, ECM
protein-mediated sequestration may play a role in diminishing
GF-mediated signaling on FN-coated dishes, especially in sys-
tems employing low doses of GF (42). In fact, because NIH-3T3
cells deposit their ownmatrix, it remains a possibility that ECM
proteins other than the adsorbed FNmay be responsible for the
observed desensitization, possibly via GF sequestration.
Although elucidating the precise role of these mechanisms is
the subject of ongoing work in our laboratory, it is especially
intriguing that adhesion-mediated desensitization occurs
selectively at low growth factor concentrations. Thus, adhesion
may play an important role in buffering cell response to noisy,
background levels of growth factor stimulation. Combinedwith
the ability to enhance signaling for select growth factors, adhe-
sion may have a net positive effect on the signal:noise ratio of
detecting and responding to growth factors. Deciphering these
and other quantitatively intricate ways in which cell adhesion
influences growth factor signaling will be crucial to developing
a better understanding of how the adhesive microenvironment
“primes” cell behaviors. Such quantitative insightwill be impor-
tant in designing syntheticmicroenvironments for applications
such as tissue engineering and regenerative medicine.
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